- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
As an SGLT2 inhibitor, the side effects of Inpefa mainly involve the urinary and reproductive system, metabolism, and skin reactions, which can...
Serpatinib (Retevmo), as a highly selective RET inhibitor, has shown significant efficacy in the treatment of RET gene mutant tumors. At the sa...
Accidental overdose of Serpatinib (Retevmo) may cause serious adverse reactions, and graded treatment measures should be taken based on specifi...
Gilteritinib has significant therapeutic effects on FLT3 mutation positive AML patients, but the discontinuation process needs to be standardiz...
Gilteritinib is an FLT3 tyrosine kinase inhibitor primarily used to treat relapsed/refractory acute myeloid leukemia (AML) with FLT3 mutation p...
Blujepa, as an antibacterial drug, has specific contraindications, dietary restrictions, and medication constraints when used. The following pr...
The therapeutic effect of Blujepa needs to be evaluated based on specific indications, and its discontinuation process should follow a gradual ...
The side effects of Acoramidis mainly include reactions in the cardiovascular and digestive systems, and corresponding relief measures should b...
Acoramidis is a medication used to treat specific cardiovascular diseases, and its indications and medication precautions must strictly follow ...
Defibrotide is mainly used to treat hepatic vein occlusion (VOD) after hematopoietic stem cell transplantation, and its use requires special at...
